All In Biotech

Drug Trial Radar · NCT06355531

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 (Oral Formulation) to Slow the Disease Progression of Progressive Supranuclear Palsy (PSP) (PROSPER)

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 241 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

241

Actual

Start

Jul 23, 2024

Primary completion

Oct 5, 2026

Study completion Oct 29, 2026

Sponsor

Lead sponsor
Ferrer Internacional S.A.Industry
Sponsor type
Industry
First posted
Apr 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PROSPER trial is a trial to assess the efficacy of FNP-223 in slowing disease progression in participants with PSP as measured by the PSP Rating Scale (PSPRS) over 52 weeks and to assess the safety and tolerability of FNP-223 for 52 weeks in participants with PSP.

Conditions

  • Progressive Supranuclear Palsy

Interventions

  • FNP-223Drug

    Oral tablets

  • PlaceboDrug

    Oral tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 52 in the PSPRS OutcomeTime frame: Baseline to Week 52
  2. Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)Time frame: Baseline to Week 52
  3. Number of Participants Experiencing Serious Adverse Events (SAEs)Time frame: Baseline to Week 52

Locations

44 sites in 9 countries. Site status is shown where the registry gives one.

  • The Neurology Center of Southern California - Carlsbad

    Carlsbad, California

  • UCSF Weill Institute for Neurosciences

    San Francisco, California

  • Rocky Mountain Movement Disorders Center

    Denver, Colorado

  • University of Miami Miller School of Medicine

    Miami, Florida

  • Augusta University

    Augusta, Georgia

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Quest Research Institute

    Farmington Hills, Michigan

  • Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai

    New York, New York

  • Columbia University Irving Medical Center

    New York, New York

  • Duke Neurology

    Durham, North Carolina

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Central Texas Neurology Consultants

    Round Rock, Texas

  • Groupe Hospitalier Pellegrin

    Bordeaux, France

  • Hôpital de la Timone

    Marseille, France

  • L'Hôpital Universitaire Carémeau

    Nîmes, France

  • Hôpital Universitaire Pitié Salpêtrière

    Paris, France

  • Hôpital Pierre-Paul Riquet

    Toulouse, France

  • Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson

    Beelitz, Germany

  • Universitätsklinikum Düsseldorf

    Düsseldorf, Germany

  • Universitätsklinikum Leipzig

    Leipzig, Germany

  • Ludwig-Maximilians-Universität München (LMU)

    Munich, Germany

  • Pécsi Tudományegyetem Általános Orvostudományi Kar

    Pécs, Hungary

  • IRCCS Istituto Delle Scienze Neurologiche di Bologna

    Bologna, Italy

  • Azienda Ospedale Università di Padova

    Padova, Italy

  • Azienda Ospedaliero-Universitaria Pisana

    Pisa, Italy

  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - San Raffaele Pisana

    Roma, Italy

  • Azienda Ospedaliera Universitaria San Giovanni di Dio Ruggi d'Aragona

    Salerno, Italy

  • Neurologia Śląska Centrum Medyczne

    Katowice, Poland

  • Mazowiecki Szpital Bródnowski w Warszawie

    Warsaw, Poland

  • Hospital de Braga

    Braga, Portugal

  • Campus Neurológico Senior - Torres Vedras

    Torres Vedras, Portugal

  • Complejo Hospitalario Universitario A Coruña

    A Coruña, Spain

  • Hospital Germans Trias i Pujol

    Badalona, Spain

  • Hospital Universitario Cruces

    Barakaldo, Spain

  • Hospital Clínic de Barcelona

    Barcelona, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

  • Hospital Universitario de Navarra

    Pamplona, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Spain

  • Hospital Universitari i Politècnic La Fe

    Valencia, Spain

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.